
Asset manager · Early to growth stage · Est. 2004
RA Capital
RA Capital is a healthcare and planetary health investor that funds and builds companies across public and private markets, backed by a large science-trained team and an in-house incubator, Raven.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is RA Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds RA Capital joined, from press and the firm’s own posts.
Every round RA Capital joined
Round sizes, RA Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company RA Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet RA Capital
Events where RA Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
RA Capital is based in Boston, United States. It also has offices in San Francisco and New York.
In 2004.
6 fund vehicles are on public registers (SEC adviser filings), including RA CAPITAL HEALTHCARE FUND, LP, RA CAPITAL NEXUS III FUND, L.P. and RA CAPITAL NEXUS II FUND, L.P.
Stages: Seed, Growth. Sectors: Life sciences, Climate and energy. From the firm’s own website.
Investment decisions rest on scientific evidence and conviction the team develops itself through an in-house research engine. It supplies capital from company formation through seed, venture, growth, IPO and public markets, and gives operational help and company-building support. From the firm’s own website.
RA Capital lists 253 portfolio companies on its website, including 89bio, Abcuro, Aclaris Therapeutics, Acrivon Therapeutics and Acumen Pharmaceuticals.
Firms whose websites list some of the same companies include Foresite Capital, Atlas Venture and Pivotal Life Sciences.
Know before RA Capital’s next round is announced.
PRO tracks RA Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.